The Dual NOD1/NOD2 Agonism of Muropeptides Containing a Meso-Diaminopimelic Acid Residue

Autor: Mikhail Pashenkov, Biana I. Alkhazova, Vyacheslav L. L’vov, Yulia A. Dagil, Nikolai P. Arbatsky, Dmitriy Mazurov
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Molecular biology
Nod2 Signaling Adaptor Protein
lcsh:Medicine
Peptide
Diaminopimelic Acid
Biochemistry
Monocytes
White Blood Cells
chemistry.chemical_compound
0302 clinical medicine
Animal Cells
Nod1 Signaling Adaptor Protein
NOD1
Medicine and Health Sciences
Small interfering RNAs
Enzyme-Linked Immunoassays
lcsh:Science
Cells
Cultured

chemistry.chemical_classification
Multidisciplinary
biology
Biological activity
Nucleic acids
Cytokines
Cellular Types
Diaminopimelic acid
Research Article
Gram-negative bacteria
Immune Cells
Immunology
DNA construction
Transfection
Microbiology
03 medical and health sciences
Residue (chemistry)
Adjuvants
Immunologic

Genetics
Humans
Non-coding RNA
Immunoassays
Gram Negative Bacteria
Blood Cells
Innate immune system
Macrophages
fungi
lcsh:R
Biology and Life Sciences
Bacteriology
Cell Biology
biology.organism_classification
Immunity
Innate

digestive system diseases
Gene regulation
Research and analysis methods
body regions
carbohydrates (lipids)
Molecular biology techniques
HEK293 Cells
030104 developmental biology
chemistry
Plasmid Construction
Immunologic Techniques
RNA
lcsh:Q
Gene expression
Peptidoglycan
030217 neurology & neurosurgery
Cloning
Zdroj: PLoS ONE, Vol 11, Iss 8, p e0160784 (2016)
PLoS ONE
ISSN: 1932-6203
Popis: Muropeptides are fragments of peptidoglycan that trigger innate immune responses by activating nucleotide-binding oligomerization domain (NOD) 1 and NOD2. Muropeptides from Gram-negative bacteria contain a meso-diaminopimelic acid (meso-DAP) residue in either a terminal or a non-terminal position. While the former ones are known to be recognized by NOD1, much less is known about recognition of muropeptides with non-terminal meso-DAP, which are most abundant moieties of Gram-negative peptidoglycans. Here, we developed a novel system to assess biological activity of muropeptides, based on CRISPR/Cas9-mediated knockout (KO) of NOD1 and NOD2 genes in modified HEK293T cells. Using NOD1/NOD2 knockout and overexpression systems, as well as human monocytes and macrophages, we refine the current view of muropeptide recognition. We show that NOD2 can recognize different natural muropeptides containing a meso-DAP residue (preferably in a non-terminal position), provided they are present at micromolar concentrations. NOD2 accepts muropeptides with long and branched peptide chains and requires an intact N-acetylmuramyl residue. Muropeptides with non-terminal meso-DAP can activate NOD1 as well, but, in this case, probably require peptidase pre-processing to expose the meso-DAP residue. Depending on NOD1/NOD2 ratio in specific cell types, meso-DAP-containing muropeptides can be recognized either primarily via NOD2 (in monocytes) or via NOD1 (in monocyte-derived macrophages and HEK293T-derived cells). The dual NOD1/NOD2 agonism of meso-DAP-containing muropeptides should be taken into account when assessing cellular responses to muropeptides and designing muropeptide immunostimulants and vaccine adjuvants.
Databáze: OpenAIRE